Paclitaxel | Docetaxel | Irinotecan | 10-DAB III | Baccatin | Sequoyitol | (2R,3S)-3-Phenylisoserine Hydrochloride | (4S,5R)-3-(tetra-butoxycarbonyl)-2,2-dimethyl-4-phenyl-oxazolidine-5-carboxylic acid | (4S,5R)-3-(3-benzoyl)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid--Shanghai Jinhe Bio-Tech Co., Ltd.

username:

paswword:

Our patent”A method of synthesizing Docetaxel” has been Officially Authorized by State Intellectual Property Office Of The People’s Republic Of China on July 30, 2008.

Our patent”A method of synthesizing Docetaxel” has been Officially Authorized by State Intellectual Property Office Of The People’s Republic Of China on July 30, 2008. The patent number: ZL 2006 1 0116735.6

	We will participate CPHI & ICSE China 2010 during June 2-4, 2010
	We will participate CPHI Worldwide 2009 during Oct. 13-15 2009
	Our project was awarded the technological invention prize of Shanghai ...
	Welcome to visit us during CPHI-SHANGHAI2008 at our booth: 4F32.
	Welcome to visit us during CPHI-SHANGHAI2008 at our booth: C36.
	Welcome to visit us during CPHI-SHANGHAI2008 at our booth: CP51083.
	Our Project Docetaxel is ranked as Innovation fund for Technology Based Firms Projects.
	Jinhe, was granted as the honor of “2005-2006 year’s advanced private enterprise “
	Jinhe’s research and development center was set up in Shanghai Juke Bio-tech Park
	A new patent of Jinhe Bio-Tec called “a new method of Docetaxel synthesis” was published.